These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26103950)

  • 1. High incidence of primary melanomas in an MC1R RHC homozygote/CDKN2A mutant genotype patient.
    Sinnya S; Jagirdar K; De'Ambrosis B; McMeniman E; Sturm RA; Soyer HP
    Arch Dermatol Res; 2015 Oct; 307(8):741-5. PubMed ID: 26103950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple melanomas after treatment for Hodgkin lymphoma in a non-Dutch p16-Leiden mutation carrier with 2 MC1R high-risk variants.
    Figl A; Thirumaran RK; Ugurel S; Gast A; Hemminki K; Kumar R; Schadendorf D
    Arch Dermatol; 2007 Apr; 143(4):495-9. PubMed ID: 17438182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population.
    Landi MT; Kanetsky PA; Tsang S; Gold B; Munroe D; Rebbeck T; Swoyer J; Ter-Minassian M; Hedayati M; Grossman L; Goldstein AM; Calista D; Pfeiffer RM
    J Natl Cancer Inst; 2005 Jul; 97(13):998-1007. PubMed ID: 15998953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High naevus count and MC1R red hair alleles contribute synergistically to increased melanoma risk.
    Duffy DL; Lee KJ; Jagirdar K; Pflugfelder A; Stark MS; McMeniman EK; Soyer HP; Sturm RA
    Br J Dermatol; 2019 Nov; 181(5):1009-1016. PubMed ID: 30820946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.
    Pastorino L; Bonelli L; Ghiorzo P; Queirolo P; Battistuzzi L; Balleari E; Nasti S; Gargiulo S; Gliori S; Savoia P; Abate Osella S; Bernengo MG; Bianchi Scarrà G
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):700-9. PubMed ID: 18983535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation.
    Eliason MJ; Hansen CB; Hart M; Porter-Gill P; Chen W; Sturm RA; Bowen G; Florell SR; Harris RM; Cannon-Albright LA; Swinyer L; Leachman SA
    Arch Dermatol; 2007 Nov; 143(11):1409-12. PubMed ID: 18025365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The interplay of sun damage and genetic risk in Australian multiple and single primary melanoma cases and controls.
    McMeniman EK; Duffy DL; Jagirdar K; Lee KJ; Peach E; McInerney-Leo AM; De'Ambrosis B; Rayner JE; Smithers BM; Soyer HP; Sturm RA
    Br J Dermatol; 2020 Aug; 183(2):357-366. PubMed ID: 31794051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype analysis in Hungarian patients with multiple primary melanoma.
    Hatvani Z; Brodszky V; Mazán M; Pintér D; Hársing J; Tóth V; Somlai B; Kárpáti S
    Exp Dermatol; 2014 May; 23(5):361-4. PubMed ID: 24660985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.
    Fargnoli MC; Gandini S; Peris K; Maisonneuve P; Raimondi S
    Eur J Cancer; 2010 May; 46(8):1413-20. PubMed ID: 20189796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The association between MC1R genotype and BRAF mutation status in cutaneous melanoma: findings from an Australian population.
    Hacker E; Hayward NK; Dumenil T; James MR; Whiteman DC
    J Invest Dermatol; 2010 Jan; 130(1):241-8. PubMed ID: 19571821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melanocortin 1 receptor (MC1R) variants in high melanoma risk patients are associated with specific dermoscopic ABCD features.
    Quint KD; van der Rhee JI; Gruis NA; Ter Huurne JA; Wolterbeek R; van der Stoep N; Bergman W; Kukutsch NA
    Acta Derm Venereol; 2012 Nov; 92(6):587-92. PubMed ID: 22965007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological features and prognostic parameters of multiple primary melanomas in CDKN2A-mutations patients.
    De Giorgi V; Savarese I; D'Errico A; Gori A; Papi F; Colombino M; Sini MC; Grazzini M; Stanganelli I; Rossari S; Covarelli P; Massi D; Palmieri G
    Pigment Cell Melanoma Res; 2015 Nov; 28(6):747-51. PubMed ID: 26223839
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeted germline sequencing of patients with three or more primary melanomas reveals high rate of pathogenic variants.
    Li C; Liu T; Tavtigian SV; Boucher K; Kohlmann W; Cannon-Albright L; Grossman D
    Melanoma Res; 2020 Jun; 30(3):247-251. PubMed ID: 31567591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of genetic factors for melanoma susceptibility in sporadic US melanoma patients.
    Council ML; Gardner JM; Helms C; Liu Y; Cornelius LA; Bowcock AM
    Exp Dermatol; 2009 May; 18(5):485-7. PubMed ID: 19320745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CDKN2A and MC1R variants found in Cypriot patients diagnosed with cutaneous melanoma.
    Koulermou G; Shammas C; Vassiliou A; Kyriakides TC; Costi C; Neocleous V; Phylactou LA; Pantelidou M
    J Genet; 2017 Mar; 96(1):155-160. PubMed ID: 28360400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.
    Potrony M; Puig-Butille JA; Aguilera P; Badenas C; Tell-Marti G; Carrera C; Javier Del Pozo L; Conejo-Mir J; Malvehy J; Puig S
    JAMA Dermatol; 2016 Apr; 152(4):405-12. PubMed ID: 26650189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDKN2A and MC1R analysis in amelanotic and pigmented melanoma.
    Ghiorzo P; Pastorino L; Pizzichetta MA; Bono R; Queirolo P; Talamini R; Annessi G; Bruno W; Nasti S; Gargiulo S; Battistuzzi L; Sini MC; Palmieri G; Scarrà GB;
    Melanoma Res; 2009 Jun; 19(3):142-5. PubMed ID: 19339902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CDKN2A/CDK4 molecular study on 155 Italian subjects with familial and/or primary multiple melanoma.
    Majore S; De Simone P; Crisi A; Eibenschutz L; Binni F; Antigoni I; De Bernardo C; Catricalà C; Grammatico P
    Pigment Cell Melanoma Res; 2008 Apr; 21(2):209-11. PubMed ID: 18363633
    [No Abstract]   [Full Text] [Related]  

  • 19. The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study.
    Berwick M; Orlow I; Hummer AJ; Armstrong BK; Kricker A; Marrett LD; Millikan RC; Gruber SB; Anton-Culver H; Zanetti R; Gallagher RP; Dwyer T; Rebbeck TR; Kanetsky PA; Busam K; From L; Mujumdar U; Wilcox H; Begg CB;
    Cancer Epidemiol Biomarkers Prev; 2006 Aug; 15(8):1520-5. PubMed ID: 16896043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple primary melanomas (MPMs) and criteria for genetic assessment: MultiMEL, a multicenter study of the Italian Melanoma Intergroup.
    Bruno W; Pastorino L; Ghiorzo P; Andreotti V; Martinuzzi C; Menin C; Elefanti L; Stagni C; Vecchiato A; Rodolfo M; Maurichi A; Manoukian S; De Giorgi V; Savarese I; Gensini F; Borgognoni L; Testori A; Spadola G; Mandalà M; Imberti G; Savoia P; Astrua C; Ronco AM; Farnetti A; Tibiletti MG; Lombardo M; Palmieri G; Ayala F; Ascierto P; Ghigliotti G; Muggianu M; Spagnolo F; Picasso V; Tanda ET; Queirolo P; Bianchi-Scarrà G
    J Am Acad Dermatol; 2016 Feb; 74(2):325-32. PubMed ID: 26775776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.